SenesTech Inc (SNES, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. SenesTech Inc is a biotech platform and research company. The Company is engaged in developing technology for managing animal pest populations through fertility control. SenesTech Inc has a market cap of $28.600 million; its shares were traded at around $1.22 with and P/S ratio of 135.55.
For the last quarter SenesTech Inc reported a revenue of $0.11 million, compared with the revenue of $0.02 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $0.30 million, an increase of 471.2% from last year.
The reported loss per diluted share was 63 cents for the year, compared with the loss per share of $2.11 in the previous year. The SenesTech Inc had an operating margin of -4000%, compared with the operating margin of -23684.62% a year before. The 10-year historical median operating margin of SenesTech Inc is -4899.31%. The profitability rank of the company is 4 (out of 10).
At the end of the fiscal year, SenesTech Inc has the cash and cash equivalents of $4.92 million, compared with $2.10 million in the previous year. The long term debt was $0.26 million, compared with $0.59 million in the previous year. SenesTech Inc has a financial strength rank of 5 (out of 10).
At the current stock price of $1.22, SenesTech Inc is traded at 10.9% discount to its historical median P/S valuation band of $1.37. The P/S ratio of the stock is 135.55, while the historical median P/S ratio is 151.91. The stock gained 139.22% during the past 12 months.
For the complete 20-year historical financial data of SNES, click here.
